SCIENOPS / THERAPEUTIC CONTEXT
Frame each programme around its biological rationale, patient population and intended use. A broad platform still needs a specific scientific evaluation.
ONCOLOGY
Example questions include target rationale, biomarker context, model relevance and how candidate evidence changes across disease settings. Evaluation requires programme-specific sources and reviewers.
NEUROLOGY
Example questions include the connection between mechanism, model endpoints, exposure and clinical interpretation. Keep the limits of each experimental or computational setting explicit.
IMMUNOLOGY
Example questions include pathway response, cell or tissue context, biomarker interpretation and relevant safety considerations. A shared evidence workflow does not make disease mechanisms interchangeable.
OTHER PROGRAMME CONTEXTS
Rare-disease, modality-specific and other programmes may require different sources, methods and acceptance criteria. Confirm the relevant depth before choosing an evaluation.
WHAT THIS PAGE REPRESENTS
These examples describe ways to frame an R&D evaluation. They are not claims of validated therapeutic expertise, clinical efficacy or patient-specific treatment selection.